Literature DB >> 4338252

Hybridization of Burkitt lymphoblastoid cells.

R Glaser, F J O'Neill.   

Abstract

Burkitt lymphoblastoid cell lines have been fused to mouse and human cell lines with the use of inactivated Sendai virus. The heterokaryons have developed into somatic cell hybrids of both parental cell types. Chromosome analyses confirm that cells now growing in selective medium are hybrids. Initial observations of preparations of the hybrid cells reveal that 5'-iododeoxyuridine can induce continued synthesis of Epstein-Barr virus antigens by these hybrid cells.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338252     DOI: 10.1126/science.176.4040.1245

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  19 in total

Review 1.  Oncogenic properties of human viruses.

Authors:  R Glaser; B Decker; F Rapp
Journal:  In Vitro       Date:  1975 May-Jun

2.  Stimulation of adenovirus replication in simian cells in the absence of a helper virus by pretreatment of the cells with iododeoxyuridine.

Authors:  M Jerkofsky; F Rapp
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

3.  Epstein-Barr virus infection of epithelial cells derived from primary cultures of adenoidal tissue.

Authors:  M Furukawa; H Sakashita; C Kato; R Umeda
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

4.  Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Authors:  Q Zhang; Y Hong; D Dorsky; E Holley-Guthrie; S Zalani; N A Elshiekh; A Kiehl; T Le; S Kenney
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.

Authors:  A L Adamson; D Darr; E Holley-Guthrie; R A Johnson; A Mauser; J Swenson; S Kenney
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.

Authors:  A L Adamson; S Kenney
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Host cell regulation of induction of Epstein-Barr virus.

Authors:  R Glaser; M Nonoyama
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  Effect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.

Authors:  J E Zimmerman; R Glaser; F Rapp
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

9.  Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells.

Authors:  R Glaser; D V Ablashi; M Nonoyama; W Henle; J Easton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

10.  Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C.

Authors:  A H Davies; R J Grand; F J Evans; A B Rickinson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.